Labiana Reports €75.2M Revenue in 2025 as Net Profit Jumps 12x
Spanish pharma group grew 13.5% in 2025, with strong CDMO performance, €11.7M adjusted EBITDA and improved leverage. MADRID, SPAIN, April 23, 2026 /EINPresswire.com/ -- Labiana, the Spanish pharmaceutical group dedicated to the development, manufacture …